Campbell MG et al., 2013. Pathway-based outlier method reveals heterogeneous genomic structure of autism in blood transcriptome. BMC Med Genomics 6:34. doi: 10.1186/1755-8794-6-34.

Frye, R et al., 2012. Metabolic effects of tetrahydrobiopterin treatment. INSAR Meeting, May 18,, Sheraton Hall, Toronto. https://imfar.confex.com/imfar/2012/webprogram/Paper11063.html

Frye RE et al., 2013. Metabolic effects of sapropterin treatment in autism spectrum disorder: a preliminary study. Transl Psychiatry. 3:e237. doi: 10.1038/tp.2013.14.

Good , P. 2015. Comment on “Metabolic effects of sapropterin treatment in autism spectrum disorder: a preliminary study” Pubpeer, Translational Psychiatry. https://pubpeer.com/publications/676B49EDA40EC126BEB69206418844

Grayson DR and A Guidott. 2016. Merging data from genetic and epigenetic approaches to better understand autistic spectrum disorder. Epigenomics. 8(1):85-104. doi: 10.2217/epi.15.92.

Hormozdiari F et al., 2015. The discovery of integrated gene networks for autism and related disorders. Genome Res 25(1):142-54. doi: 10.1101/gr.178855.114.

Kelleher RJ 3^rd 2012. High-throughput sequencing of mGluR signaling pathway genes reveals enrichment of rare variants in autism. PLoS One. 7(4):e35003. doi: 10.1371/journal.pone.0035003.

Kumar A et al., 2011. A brain region-specific predictive gene map for autism derived by profiling a reference gene set. PLoS One. 6(12):e28431. doi: 10.1371/journal.pone.0028431.

Liu L et al., 2014. DAWN: a framework to identify autism genes and subnetworks using gene expression and genetics. Mol Autism. 5(1):22. doi: 10.1186/2040-2392-5-22.

Skafidas et al., 2014. Predicting the diagnosis of autism spectrum disorder using gene pathway analysis. Mol Psychiatry. 19(4):504-10. doi: 10.1038/mp.2012.126.

Soliman ML et al., 2013. Acetate reduces PGE2 release and modulates phospholipase and cyclooxygenase levels in neuroglia stimulated with lipopolysaccharide. Lipids. 48(7):651-62. doi: 10.1007/s11745-013-3799-x.

Wenger TL et al., 2016. The role of mGluR copy number variation in genetic and environmental forms of syndromic autism spectrum disorder. Sci Rep. 6:19372. doi: 10.1038/srep19372.

Zeidán-Chuliá F et al., 2015. Up-regulation of oligodendrocyte lineage markers in the cerebellum of autistic patients: evidence from network analysis of gene expression. Mol Neurobiol. Jul 21. Pp1-7. doi:10.1007/s12035-015-9351-7

Zikopoulos B and H. Barbas, 2010. Changes in prefrontal axons may disrupt the network in autism. J Neurosci. 30(44):14595-609. doi: 10.1523/JNEUROSCI.2257-10.2010.